Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$1.77B |
| 2 |
Microsoft
MSFT
|
$1.65B |
| 3 |
NVIDIA
NVDA
|
$1.47B |
| 4 |
Gilead Sciences
GILD
|
$1.13B |
| 5 |
Kroger
KR
|
$1.03B |
Top Sells
| 1 |
Procter & Gamble
PG
|
$1.34B |
| 2 |
Apple
AAPL
|
$1.23B |
| 3 |
United Parcel Service
UPS
|
$1.09B |
| 4 |
American Express
AXP
|
$999M |
| 5 |
JPMorgan Chase
JPM
|
$969M |
Sector Composition
| 1 | Technology | 24.89% |
| 2 | Financials | 15.95% |
| 3 | Healthcare | 15.37% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Payoneer
PAYO
$2.4B
| $1.43M | ﹤0.01% |
348,966
-1,906,751
| -85% | -$7.84M |
|
1552
Nuvation Bio
NUVB
$1.33B
| $1.43M | ﹤0.01% |
733,542
+40,869
| +6% | +$79.7K |
|
1553
Rhythm Pharmaceuticals
RYTM
$6.78B
| $1.42M | ﹤0.01% |
22,425
-1,133
| -5% | -$71.6K |
|
1554
CubeSmart
CUBE
$9.52B
| $1.4M | ﹤0.01% |
33,032
+3,307
| +11% | +$141K |
|
1555
Cullinan Oncology
CGEM
$413M
| $1.4M | ﹤0.01% |
186,083
+25,026
| +16% | +$188K |
|
1556
Krystal Biotech
KRYS
$4.35B
| $1.4M | ﹤0.01% |
10,153
-446
| -4% | -$61.3K |
|
1557
Dianthus Therapeutics
DNTH
$853M
| $1.39M | ﹤0.01% |
74,351
+6,369
| +9% | +$119K |
|
1558
Vanda Pharmaceuticals
VNDA
$272M
| $1.38M | ﹤0.01% |
292,495
+26,607
| +10% | +$126K |
|
1559
Southern First Bancshares
SFST
$366M
| $1.37M | ﹤0.01% |
35,981
+1,872
| +5% | +$71.2K |
|
|
HIMX
1560
Himax Technologies
HIMX
$1.46B
| $1.35M | ﹤0.01% |
151,682
-305,143
| -67% | -$2.72M |
|
1561
Alamos Gold
AGI
$13.5B
| $1.35M | ﹤0.01% |
+50,945
| New | +$1.35M |
|
1562
SIGA Technologies
SIGA
$603M
| $1.35M | ﹤0.01% |
206,329
+24,001
| +13% | +$156K |
|
|
SWTX
1563
DELISTED
SpringWorks Therapeutics
SWTX
| $1.34M | ﹤0.01% |
28,460
-2,103
| -7% | -$98.8K |
|
1564
Rivian
RIVN
$17.2B
| $1.33M | ﹤0.01% |
96,789
+3,991
| +4% | +$54.8K |
|
1565
Cummins
CMI
$55.1B
| $1.33M | ﹤0.01% |
4,056
+527
| +15% | +$173K |
|
1566
Celcuity
CELC
$2.36B
| $1.33M | ﹤0.01% |
99,379
+14,554
| +17% | +$194K |
|
1567
Unitil
UTL
$827M
| $1.33M | ﹤0.01% |
25,413
+2,308
| +10% | +$120K |
|
1568
Capricor Therapeutics
CAPR
$308M
| $1.31M | ﹤0.01% |
131,877
+21,146
| +19% | +$210K |
|
1569
Teradyne
TER
$19.1B
| $1.3M | ﹤0.01% |
14,498
+679
| +5% | +$61.1K |
|
1570
Tourmaline Bio
TRML
$687M
| $1.3M | ﹤0.01% |
81,076
+6,337
| +8% | +$101K |
|
1571
Atea Pharmaceuticals
AVIR
$267M
| $1.29M | ﹤0.01% |
359,451
+54,921
| +18% | +$198K |
|
1572
Zevra Therapeutics
ZVRA
$502M
| $1.29M | ﹤0.01% |
146,284
+5,866
| +4% | +$51.7K |
|
1573
Futu Holdings
FUTU
$26.1B
| $1.29M | ﹤0.01% |
10,399
+7,888
| +314% | +$975K |
|
1574
Brighthouse Financial
BHF
$2.48B
| $1.27M | ﹤0.01% |
23,633
-9,701
| -29% | -$522K |
|
1575
Terns Pharmaceuticals
TERN
$632M
| $1.25M | ﹤0.01% |
335,169
+14,006
| +4% | +$52.2K |
|